A genetic “Minority Report”: How corporate DNA testing could put us at risk
By Benjamin Winterhalter,
Salon
| 01. 26. 2014
On Nov. 22, 2013, the FDA sent a now-infamous letter to the genetic
research startup 23andMe, ordering the company to stop marketing some of
its personal DNA testing kits. In its letter, the agency told 23andMe
that it was concerned about the possibility of erroneous test results,
about false positives and false negatives. The FDA warned that false
positives – for example, being told that one has a high risk of breast
cancer when really one doesn’t – might lead customers to seek expensive
testing or medical treatment that they don’t really need. False
negatives – which are just the opposite – might lead customers to ignore
serious health problems or deviate from a prescribed treatment regime.
The company had been out of contact with the FDA since May of 2013, and
had not filed the required information to allay the bureau’s concerns.
When
word about the letter got out, the ever-ready machine of Internet
journalism whirred quickly to life. Defenders of the genetic research
firm argued that the information, if used properly and with a
physician’s supervision, is not only...
Related Articles
By Alondra Nelson, Science | 09.11.2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
By Johana Bhuiyan, The Guardian | 09.23.2025
In March 2021, a 25-year-old US citizen was traveling through Chicago’s Midway airport when they were stopped by US border patrol agents. Though charged with no crime, the 25-year-old was subjected to a cheek swab to collect their DNA, which...
By Julie Métraux, Mother Jones | 09.23.2025